|
1
|
Shrestha AD, Neupane D, Vedsted P and Kallestrup P: Cervical cancer prevalence, incidence and mortality in low and middle income countries: A systematic review. Asian Pacific journal of cancer prevention. Asian Pac J Cancer Prev. 19:319–324. 2018.PubMed/NCBI
|
|
2
|
Dykens JA, Linn AM, Irwin T, Peters KE, Pyra M, Traoré F, Touré Diarra M, Hasnain M, Wallner K, Linn P, et al: Implementing visual cervical cancer screening in Senegal: A cross-sectional study of risk factors and prevalence highlighting service utilization barriers. Int J Womens Health. 9:59–67. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Escobar N and Plugge E: Prevalence of human papillomavirus infection, cervical intraepithelial neoplasia and cervical cancer in imprisoned women worldwide: A systematic review and meta-analysis. J Epidemiol Community Health. 74:95–102. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cohen PA, Jhingran A, Oaknin A and Denny L: Cervical cancer. Lancet. 393:169–182. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Peng L, Yuan X, Jiang B, Tang Z and Li GC: LncRNAs: Key players and novel insights into cervical cancer. Tumour Biol. 37:2779–2788. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bahrami A, Hasanzadeh M, ShahidSales S, Yousefi Z, Kadkhodayan S, Farazestanian M, Joudi Mashhad M, Gharib M, Mahdi Hassanian S and Avan A: Clinical significance and prognosis value of Wnt signaling pathway in cervical cancer. J Cell Biochem. 118:3028–3033. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Aalijahan H and Ghorbian S: Long non-coding RNAs and cervical cancer. Exp Mol Pathol. 106:7–16. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yuan LY, Qin X, Li L, Zhou J, Zhou M, Li X, Xu Y, Wang XJ and Xing H: The transcriptome profiles and methylation status revealed the potential cancer-related lncRNAs in patients with cervical cancer. J Cell Physiol. 234:9756–9763. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huang J, Liu T, Shang C, Zhao Y, Wang W, Liang Y, Guo L and Yao S: Identification of lncRNAs by microarray analysis reveals the potential role of lncRNAs in cervical cancer pathogenesis. Oncol Lett. 15:5584–5592. 2018.PubMed/NCBI
|
|
10
|
Yu X, Li Z, Zheng H, Chan MT and Wu WKK: NEAT 1: A novel cancer-related long non-coding RNA. Cell Prolif. 50:e123292017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun C, Li S, Zhang F, Xi Y, Wang L, Bi Y and Li D: Long non-coding RNA NEAT1 promotes non-small cell lung cancer progression through regulation of miR-377-3p-E2F3 pathway. Oncotarget. 7:51784–51814. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li W, Zhang Z, Liu X, Cheng X, Zhang Y, Han X, Zhang Y, Liu S, Yang J, Xu B, et al: The FOXN3-NEAT1-SIN3A repressor complex promotes progression of hormonally responsive breast cancer. J Clin Invest. 127:3421–3440. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yuan LY, Zhou M, Lv H, Qin X, Zhou J, Mao X, Li X, Xu Y, Liu Y and Xing H: Involvement of NEAT1/miR-133a axis in promoting cervical cancer progression via targeting SOX4. J Cell Physiol. 234:18985–18993. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xie Q, Lin S, Zheng M, Cai Q and Tu Y: Long noncoding RNA NEAT1 promotes the growth of cervical cancer cells via sponging miR-9-5p. Biochem Cell Biol. 97:100–108. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Trang P, Weidhaas JB and Slack FJ: MicroRNAs and cancer. The Molecular Basis of Human Cancer. Springer; New York, NY: pp. 277–286. 2017, View Article : Google Scholar
|
|
16
|
Park S, Eom K, Kim J, Bang H, Wang HY, Ahn S, Kim G, Jang H, Kim S, Lee D, et al: MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer. BMC Cancer. 17:6582017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Babion I, Jaspers A, van Splunter AP, van der Hoorn IA, Wilting SM and Steenbergen RD: miR-9-5p exerts a dual role in cervical cancer and targets transcription factor TWIST1. Cells. 9:652019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wu H, Liu HY, Liu WJ, Shi YL and Dawei Bao D: miR-377-5p inhibits lung cancer cell proliferation, invasion, and cell cycle progression by targeting AKT1 signaling. J Cell Biochem. Nov 28–2018.(Epub ahead of print). doi: 10.1002/jcb.28091.
|
|
19
|
Li B, Xu WW, Han L, Chan KT, Tsao SW, Lee NP, Law S, Xu LY, Li EM, Chan KW, et al: MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGF. Oncogene. 36:3986–4000. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhan W, Liao X, Chen Z, Li L, Tian T, Yu L, Wang W and Hu Q: Circular RNA hsa_circRNA_103809 promoted hepatocellular carcinoma development by regulating miR-377-3p/FGFR1/ERK axis. J Cell Physiol. 235:1733–1745. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yuan H, Li ZM, Shao J, Ji WX, Xia W and Lu S: FGF2/FGFR1 regulates autophagy in FGFR1-amplified non-small cell lung cancer cells. J Exp Clin Cancer Res. 36:722017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu SF, Zhu HC, Gu FH, Huang BY and Liu HY: Characteristics of an established cervical carcinoma cell line HCE1. Hunan I Ko Ta Hsueh Hsueh Pao. 25:532–534. 2000.(In Chinese). PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−ΔΔC(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tornesello ML, Faraonio R, Buonaguro L, Annunziata C, Starita N, Cerasuolo A, Pezzuto F, Tornesello AL and Buonaguro FM: The role of microRNAs, long non-coding RNAs, and circular RNAs in cervical cancer. Front Oncol. 10:1502020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Peng WX, Koirala P and Mo YY: LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 36:5661–5667. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rupaimoole R and Slack FJ: MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 16:203–222. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Han D, Wang J and Cheng G: LncRNA NEAT1 enhances the radio-resistance of cervical cancer via miR-193b-3p/CCND1 axis. Oncotarget. 9:2395–2409. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ye C, Hu Y and Wang J: MicroRNA-377 targets zinc finger E-box-binding homeobox 2 to inhibit cell proliferation and invasion of cervical cancer. Oncol Res. 27:183–192. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang P, Wu T, Zhou H, Jin Q, He G, Yu H, Xuan L, Wang X, Tian L, Sun Y, et al: Long noncoding RNA NEAT1 promotes laryngeal squamous cell cancer through regulating miR-107/CDK6 pathway. J Exp Clin Cancer Res. 35:222016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jen J, Tang YA, Lu YH, Lin CC, Lai WW and Wang YC: Oct4 transcriptionally regulates the expression of long non-coding RNAs NEAT1 and MALAT1 to promote lung cancer progression. Mol Cancer. 16:1042017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang M, Wu WB, Wang ZW and Wang XH: lncRNA NEAT1 is closely related with progression of breast cancer via promoting proliferation and EMT. Eur Rev Med Pharmacol Sci. 21:1020–1026. 2017.PubMed/NCBI
|
|
32
|
An J, Lv W and Zhang Y: LncRNA NEAT1 contributes to paclitaxel resistance of ovarian cancer cells by regulating ZEB1 expression via miR-194. OncoTargets Ther. 10:5377–5390. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Rastogi B, Kumar A, Raut SK, Panda NK, Rattan V, Joshi N and Khullar M: Downregulation of miR-377 promotes oral squamous cell carcinoma growth and migration by targeting HDAC9. Cancer Invest. 35:152–162. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Azizi M, Fard-Esfahani P, Mahmoodzadeh H, Fazeli MS, Azadmanesh K, Zeinali S and Teimoori-Toolabi L: MiR-377 reverses cancerous phenotypes of pancreatic cells via suppressing DNMT1 and demethylating tumor suppressor genes. Epigenomics. 9:1059–1075. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang K, Ji W, Yu Y, Li Z, Niu X, Xia W and Lu S: FGFR1-ERK1/2-SOX2 axis promotes cell proliferation, epithelial-mesenchymal transition, and metastasis in FGFR1-amplified lung cancer. Oncogene. 37:5340–5354. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Golfmann K, Meder L, Koker M, Volz C, Borchmann S, Tharun L, Dietlein F, Malchers F, Florin A, Büttner R, et al: Synergistic anti-angiogenic treatment effects by dual FGFR1 and VEGFR1 inhibition in FGFR1-amplified breast cancer. Oncogene. 37:5682–5693. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Formisano L, Stauffer KM, Young CD, Bhola NE, Guerrero-Zotano AL, Jansen VM, Estrada MM, Hutchinson KE, Giltnane JM, Schwarz LJ, et al: Association of FGFR1 with ERα maintains ligand-independent ER transcription and mediates resistance to estrogen deprivation in ER+ breast cancer. Clin Cancer Res. 23:6138–6150. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gong J, Jiang H, Shu C, Hu MQ, Huang Y, Liu Q, Li RF and Wei YZ: Integrated analysis of circular RNA-associated ceRNA network in cervical cancer: Observational Study. Medicine (Baltimore). 98:e169222019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Meng Q, Li Y, Kong C, Gao X and Jiang X: Circ_0000388 exerts oncogenic function in cervical cancer cells by regulating miR-337-3p/TCF12 axis. Cancer Biother Radiopharm. 36:58–69. 2021. View Article : Google Scholar : PubMed/NCBI
|
